iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare company that develops wearable cardiac monitoring solutions for the diagnosis of heart arrhythmias. Its core product, the Zio ECG monitor, is a single-use wearable patch that patients wear for up to 14 days, capturing continuous, high-quality ECG data over extended periods. The company was founded in 2006 and is led by CEO Quentin Blackford.

The company's work sits at the intersection of wearable medical devices and applied artificial intelligence. Its technical domains include deep learning, ECG signal analysis and FDA-cleared AI algorithms. iRhythm reports that its AI has been clinically proven to be as accurate as expert cardiologists in analysing cardiac data.

According to the company, more than 8 million patients have been served and over 1.5 billion hours of heartbeat data have been analysed. iRhythm operates in the United States, the United Kingdom and Japan, and is publicly listed on Nasdaq under the ticker IRTC.

The company describes its mission as innovating trusted solutions that detect, predict and prevent disease, with an emphasis on cardiac care and patient-comfort-centred product design.